<DOC>
	<DOCNO>NCT01395927</DOCNO>
	<brief_summary>The purpose study evaluate blood level canagliflozin healthy volunteer administration multiple-doses rifampin .</brief_summary>
	<brief_title>A Study Evaluate Effects Rifampin Single-Dose Pharmacokinetics Canagliflozin Healthy Volunteers</brief_title>
	<detailed_description>This open-label ( volunteer study staff know identity study drug assign ) study canagliflozin rifampin take sequential order healthy volunteer 12 day . Healthy volunteer take orally ( mouth ) one 300 mg canagliflozin tablet and/or two 300 mg rifampin capsule daily sequential order follow : Day 1 volunteer take one 300-mg canagliflozin tablet , Days 4 9 volunteer take two 300-mg rifampin capsule daily , Day 10 volunteer take one 300-mg canagliflozin tablet + two 300-mg rifampin capsule , Days 11 12 volunteer take two 300-mg rifamplin capsule daily .</detailed_description>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Healthy volunteer body mass index 18 30 kg/m2 ( inclusive ) History current medical illness deem clinically significant Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Canagliflozin</keyword>
	<keyword>Rifampin</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>